Literature DB >> 12075714

Fatal myeloencephalitis following yellow fever vaccination in a case with HIV infection.

Kitisak Kengsakul1, Kriengkrai Sathirapongsasuti, Sompone Punyagupta.   

Abstract

A 53 year old physically healthy man, unaware of any immunocompromised condition developed rapidly fatal myelomeningoencephalitis following a live-attenuated yellow fever vaccination. He was found to have asymptomatic HIV infection with high viral loads and low CD4 counts. This is the first reported case of such an incidence in the world literature. It is strongly suggested that in countries where HIV infection is endemic, an HIV blood test should be performed prior to the yellow fever vaccination and the vaccine should not be given to those immunocompromised persons.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12075714

Source DB:  PubMed          Journal:  J Med Assoc Thai        ISSN: 0125-2208


  19 in total

1.  Yellow Fever Immunizations: Indications and Risks.

Authors:  Mary E. Wilson; Lin H. Chen; Elizabeth D. Barnett
Journal:  Curr Infect Dis Rep       Date:  2004-02       Impact factor: 3.725

2.  Mapping the risk of yellow Fever infection.

Authors:  David R Hill
Journal:  Curr Infect Dis Rep       Date:  2012-06       Impact factor: 3.725

Review 3.  The safety of yellow fever vaccine 17D or 17DD in children, pregnant women, HIV+ individuals, and older persons: systematic review.

Authors:  Roger E Thomas; Diane L Lorenzetti; Wendy Spragins; Dave Jackson; Tyler Williamson
Journal:  Am J Trop Med Hyg       Date:  2012-02       Impact factor: 2.345

Review 4.  Advances and controversies in yellow fever vaccination.

Authors:  Emile F F Jonker; Leonardus G Visser; Anna H Roukens
Journal:  Ther Adv Vaccines       Date:  2013-11

5.  Live virus vaccines in transplantation: friend or foe?

Authors:  Charlotte M Verolet; Klara M Posfay-Barbe
Journal:  Curr Infect Dis Rep       Date:  2015-04       Impact factor: 3.725

Review 6.  Immunization of HIV-infected adult patients - French recommendations.

Authors:  Anne Frésard; Amandine Gagneux-Brunon; Frédéric Lucht; Elisabeth Botelho-Nevers; Odile Launay
Journal:  Hum Vaccin Immunother       Date:  2016-07-13       Impact factor: 3.452

Review 7.  Immunization after kidney transplantation-what is necessary and what is safe?

Authors:  Camille N Kotton
Journal:  Nat Rev Nephrol       Date:  2014-07-29       Impact factor: 28.314

Review 8.  Vaccination in HIV-infected adults.

Authors:  Nancy F Crum-Cianflone; Mark R Wallace
Journal:  AIDS Patient Care STDS       Date:  2014-07-16       Impact factor: 5.078

Review 9.  Efficacy and duration of immunity after yellow fever vaccination: systematic review on the need for a booster every 10 years.

Authors:  Eduardo Gotuzzo; Sergio Yactayo; Erika Córdova
Journal:  Am J Trop Med Hyg       Date:  2013-09       Impact factor: 2.345

10.  Activity of T-705 in a hamster model of yellow fever virus infection in comparison with that of a chemically related compound, T-1106.

Authors:  Justin G Julander; Kristiina Shafer; Donald F Smee; John D Morrey; Yousuke Furuta
Journal:  Antimicrob Agents Chemother       Date:  2008-10-27       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.